Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2

Journal of Experimental Medicine

Volumn 192, Issue 10, 2000, Pages 1441-1451

  Biedermann, Tilo ^a   Kneilling, Manfred ^a   Mailhammer, Reinhard ^b   Maier, Konrad ^c   Sander, Christian A ^a   Kollias, George ^d   Kunkel, Steven L ^e   Hültner, Lothar ^b   Röcken, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d HELLENIC PASTEUR INSTITUTE   (Greece)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune disease; Chemokines; Cytokines; Inflammation; Type 1 T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; INFLAMMATION; MAST CELL; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; DERMATITIS, CONTACT; FEMALE; HYPERSENSITIVITY, DELAYED; LEUKOCYTES; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MONOKINES; NEUTROPHILS; PICRYL CHLORIDE; PROTO-ONCOGENE PROTEINS C-KIT; SKIN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034693950     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.10.1441     Document Type: Article

References (63)

1. Immunology of reactive arthritides
2. Role of cytokines in rheumatoid arthritis
3. Seeing the wood for the trees: The forgotten role of neutrophils in rheumatoid arthritis
4. Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice
5. Th1/Th2 cells
6. The immunopathology of psoriasis
7. Skin innate immune system in psoriasis: Friend or foe?
8. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
9. Chemokine expression in murine experimental allergic encephalomyelitis
10. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha
11. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
12. Lymphocyte homing and homeostasis
13. Chemokines and leukocyte traffic
14. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice
15. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice
16. Chemokines: A new classification system and their role in immunity
17. Solution structure of murine macrophage inflammatory protein-2
18. Groalpha-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity
19. Tumor necrosis factor: A master-regulator of leukocyte movement
20. The pathophysiology of tumor necrosis factors
21. Functional diversity of helper T lymphocytes
22. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: A possible initiating role of B cells
23. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice
24. Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4
25. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin
26. Human mast cells produce IL-8
27. Allergy
28. Human intestinal mast cells are capable of producing different cytokine profiles: Role of IgE receptor cross-linking and IL-4
29. Critical protective role of mast cells in a model of acute septic peritonitis
30. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha
31. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate
32. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis
33. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice
34. Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4
35. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
36. Immune and inflammatory responses in TNF-α-deficient mice: A critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
37. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis
38. Schistosoma mansoni infection in mice augments the capacity for interleukin 3 (IL-3) and IL-9 production and concurrently enlarges progenitor pools for mast cells and granulocytes-macrophages
39. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9
40. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions
41. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes
42. + T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
43. Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein-2 and mast cells in experimental peritonitis
44. Cytokine networks in the skin
45. Early molecular events in the induction phase of contact sensitivity
46. Inflammatory skin diseases, T cells, and immune surveillance
47. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha
48. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody
49. Expression and regulation of chemokines in bacterial pneumonia
50. Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract
51. Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: Dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation
52. Multifunctional cytokine expression by human mast cells: Regulation by T cell membrane contact and glucocorticoids
53. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice
54. The two faces of the mast cell
55. FcεRI-induced cytokine production and gene expression
56. TGFβ1 and TNFα secreted by mast cells stimulated via the FcepsilonRI activate fibroblasts for high-level production of monocyte chemoattractant protein-1 (MCP-1)
57. The mast cell in health and disease
58. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis
59. Arthritis and mast cell activation
60. Strictures in Crohn's disease are characterized by an accumulation of mast cells colocalized with laminin but not with fibronectin or vitronectin
61. Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue
62. Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis
63. Rheumatoid arthritis